MD-224 |
Degrader (PROTAC) of MDM2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MDM2 |
|
|
Degrader (PROTAC)
In certain cell lines (e.g, MV411), concentrations > 30 nM may be needed to achieve complete degradation of MDM2 after treatment for 2h.
up to 30 nM
Selectivity
In Cell Selectivity Assessment
Potency Assay Off-Target:
Cell Growth Inhibition Activity
Selectivity Assessment Description:
Cell Growth Inhibition Activity of MD-224 in a Panel of Human AML or ALL Cell Lines MOLM-13 7.3 nM, ...
Potency Cellular
In Vitro
MDM2
Mode of Action: Degrader (PROTAC)
Structure-Activity-Relationship data available? No
DOI Reference: 10.1021/acs.jmedchem.8b00909
In Vivo Validations
Mouse
Dose: 25 mg/Kg IV once weekly, 10 mg/Kg 3 times weekly, 25 mg/Kg 5 days a week for 2 weeks, 50 mg/Kg every other day for 3 weeks
Route of delivery:
Intravenous
DOI Reference: 10.1021/acs.jmedchem.8b00909
Orthogonal Probes def
MG-277
Chemical Information
| Molecular Formula | C48H43Cl2FN6O6 |
| SMILEs | O=C1CCC(N2Cc3c(C#CCCCNC(=O)c4ccc(NC(=O)[C@@H]5NC6(CCCCC6)[C@@]6(C(=O)Nc7cc(Cl)ccc76)[C@H]5c5cccc(Cl)c5F)cc4)cccc3C2=O)C(=O)N1 |
| InChI | InChI=1S/C48H43Cl2FN6O6/c49-29-16-19-34-36(25-29)54-46(63)48(34)39(32-12-8-13-35(50)40(32)51)41(56-47(48)22-4-2-5-23-47)44(61)53-30-17-14-28(15-18-30)42(59)52-24-6-1-3-9-27-10-7-11-31-33(27)26-57(45(31)62)37-20-21-38(58)55-43(37)60/h7-8,10-19,25,37,39,41,56H,1-2,4-6,20-24,26H2,(H,52,59)(H,53,61)(H,54,63)(H,55,58,60)/t37?,39-,41+,48+/m0/s1 |
| Molecular weight | 888.26 Da |
| AlogP | 0.0 |
| HBond acceptors | 12 |
| HBond donors | 5 |
| Atoms | 106 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.